Ciber-bbn

Ciber-bbn, founded in 2006, is a consortium focused on advancing biomedical research in bioengineering, biomaterials, and nanomedicine. It prioritizes knowledge transfer and collaboration in clinical and technological innovation, serving researchers, healthcare professionals, and institutions. The organization aims to bridge fundamental research with practical applications, driving scientific discovery and enhancing patient care through cutting-edge biomedical advancements.

Employing 500 - 1,000 professionals, Ciber-bbn demonstrates substantial capacity in the biomedical research field. It actively promotes its initiatives through scientific events and offers specialized training programs. Meet Ciber-bbn's team to understand the expertise driving their work in bioengineering, biomaterial development, and clinical research, aiming for both basic scientific understanding and tangible healthcare solutions.

Ciber-bbn generated $148.4M in revenue, reflecting its significant economic impact. Its focus on internationalization and collaboration positions it within the European and North American biomedical landscape, with connections to Spain and Mexico. By concentrating on bioengineering and nanomedicine, Ciber-bbn aligns with emerging healthcare technology trends. Its commitment to innovation and knowledge dissemination solidifies its role in shaping the future of biomedical science.